BNP Paribas Financial Markets
VPHM

BNP Paribas Financial Markets’s VIROPHARMA INC VPHM Stock Holding History

BNP Paribas Financial Markets’s Portfolio VPHM Stock Details VPHM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-18,130
Closed -$712K – 4183
2013
Q3 		$712K Sell
18,130
-4,585
-20% -$150K ﹤0.01% 1319
2013
Q2 		$651K Buy
+22,715
New +$599K ﹤0.01% 1315

Other funds holding VPHM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BNP Paribas Financial Markets's VPHM Position: Q4 2013 in Review

BNP Paribas Financial Markets sold out of VIROPHARMA INC (VPHM) in Q4 2013, closing a stake of 18,130 shares — an estimated $712K sold.

BNP Paribas Financial Markets first reported a position in VPHM in Q2 2013 and held it in 2 quarters. The position peaked at $712K in Q3 2013. 172 funds tracked by Wall St. Rank hold VPHM as of Q4 2013.

  • BNP Paribas Financial Markets reported no remaining VIROPHARMA INC position as of Q4 2013 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 18,130 VIROPHARMA INC shares in Q4 2013, an estimated $712K.
  • BNP Paribas Financial Markets first reported a position in VIROPHARMA INC in Q2 2013 and held it in 2 quarters.
  • BNP Paribas Financial Markets's VIROPHARMA INC position peaked at $712K in Q3 2013.
  • 172 funds tracked by Wall St. Rank held VIROPHARMA INC as of Q4 2013.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2013, filed 12 Feb 2014.